Celularity Inc
CELU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001752828
No open-market purchases or sales by Celularity Inc insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $2.44M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Celularity Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −4 vs. Q1 2024
- Shares held
- 944.8K
- +97.9K (+11.6%) vs. Q1 2024
- Total value
- $2.96M
- −$1.42M (−32.5%) vs. Q1 2024
- New holders
- 0
- 7 more added
- Sold out
- 4
- 8 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CELU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $2.44M |
| Q1 2026 | 38 | $2.88M |
| Q4 2025 | 36 | $3.19M |
| Q3 2025 | 38 | $4.76M |
| Q2 2025 | 34 | $4.27M |
| Q1 2025 | 29 | $3.43M |
| Q4 2024 | 32 | $3.85M |
| Q3 2024 | 27 | $2.86M |
| Q2 2024 | 26 | $2.96M |
| Q1 2024 | 30 | $4.38M |
| Q4 2023 | 37 | $2.05M |
| Q3 2023 | 45 | $8.02M |
| Q2 2023 | 56 | $18.8M |
| Q1 2023 | 61 | $21.3M |
| Q4 2022 | 73 | $44.2M |
| Q3 2022 | 72 | $81.0M |
| Q2 2022 | 66 | $105.1M |
| Q1 2022 | 37 | $232.0M |
| Q4 2021 | 25 | $85.6M |
| Q3 2021 | 21 | $8.42M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Celularity Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 16 | $50 | 0.00% | 00.0% | Unchanged |
| Pacific Capital Wealth Advisors, Inc | 50 | $157 | 0.00% | 00.0% | Unchanged |
| Bray Capital Advisors | 100 | $313 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 157 | $491 | 0.00% | −44−21.9% | Reduced |
| Financial Perspectives, Inc | 171 | $535 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 189 | $591 | 0.00% | 00.0% | Unchanged |
| Weaver Capital Management LLC | 300 | $939 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 300 | $939 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 350 | $1.10K | 0.00% | −8,500−96.0% | Reduced |
| HighMark Wealth Management LLC | 441 | $1.38K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1,000 | $3.13K | 0.00% | −12,000−92.3% | Reduced |
| UBS Group AG | 1,215 | $3.80K | 0.00% | −2−0.2% | Reduced |
| Tower Research Capital LLC (TRC) | 1,975 | $6.18K | 0.00% | −4,940−71.4% | Reduced |
| Bank of America Corp | 2,284 | $7.15K | 0.00% | −155−6.4% | Reduced |
| Simplex Trading, LLC | 5,432 | $17.0K | 0.00% | +3,675+209.2% | Added |
| Keynote Financial Services LLC | 13,160 | $41.2K | 0.03% | −2,406−15.5% | Reduced |
| IPG Investment Advisors LLC | 17,169 | $53.7K | 0.01% | 00.0% | Unchanged |
| Royal Bank of Canada | 22,827 | $71.0K | 0.00% | +327+1.5% | Added |
| HB Wealth Management, LLC | 24,000 | $75.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 25,498 | $79.8K | 0.00% | −4,270−14.3% | Reduced |
| State Street Corp | 26,630 | $83.4K | 0.00% | +1,700+6.8% | Added |
| Northern Trust Corp | 34,062 | $106.6K | 0.00% | +6,717+24.6% | Added |
| Cresset Asset Management, LLC | 35,000 | $109.5K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 90,748 | $284.0K | 0.00% | +14,389+18.8% | Added |
| Geode Capital Management, LLC | 141,555 | $443.2K | 0.00% | +6,912+5.1% | Added |
| Vanguard Group Inc | 500,132 | $1.57M | 0.00% | +115,214+29.9% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,012−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,107−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |